tiprankstipranks
Trending News
More News >
Caribou Biosciences (CRBU)
NASDAQ:CRBU
US Market

Caribou Biosciences (CRBU) Financial Statements

Compare
895 Followers

Caribou Biosciences Financial Overview

Caribou Biosciences's market cap is currently $131.79M. The company's EPS TTM is $-0.3; its P/E ratio is -0.83; Caribou Biosciences is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 9.99M$ 34.48M$ 13.85M$ 9.60M$ 12.36M
Gross Profit$ 6.07M$ 30.95M$ 10.21M$ 8.61M$ -22.06M
Operating Income$ -166.62M$ -116.06M$ -106.40M$ -66.98M$ -36.12M
EBITDA$ -162.69M$ -112.53M$ -95.71M$ -65.61M$ -35.21M
Net Income$ -149.10M$ -102.07M$ -99.42M$ -66.92M$ -34.31M
Balance Sheet
Cash & Short-Term Investments$ 209.54M$ 328.83M$ 247.66M$ 375.83M$ 15.95M
Total Assets$ 313.31M$ 432.21M$ 373.76M$ 442.36M$ 36.05M
Total Debt$ 26.49M$ 27.11M$ 27.75M$ 259.00K$ 1.58M
Net Debt$ 10.19M$ -24.05M$ -30.59M$ -240.42M$ -14.38M
Total Liabilities$ 60.36M$ 63.81M$ 72.89M$ 54.53M$ 59.48M
Stockholders' Equity$ 252.95M$ 368.40M$ 300.87M$ 387.82M$ -23.44M
Cash Flow
Free Cash Flow$ -144.71M$ -104.90M$ -97.42M$ -35.64M$ -34.53M
Operating Cash Flow$ -138.20M$ -93.29M$ -90.97M$ -32.52M$ -33.22M
Investing Cash Flow$ 86.61M$ -68.18M$ -93.25M$ -176.40M$ 6.36M
Financing Cash Flow$ 16.72M$ 154.30M$ 2.13M$ 433.43M$ 1.74M
Currency in USD

Caribou Biosciences Earnings and Revenue History

Caribou Biosciences Debt to Assets

Caribou Biosciences Cash Flow

Caribou Biosciences Forecast EPS vs Actual EPS